SFV HEALTHCARE

Bio Science Panel Talks Up Conejo Valley

Conejo Valley’s senior biotech executives discussed why they put down roots in the region at the BioScience Alliance’s Panel Event on Wednesday in Thousand Oaks.

Valley Senior Facilities Sold in Portfolio

Two Valley eldercare facilities have traded hands as part of a $378 million portfolio to an Orange County health care property owner.

CSUN, Dignity Health Sign Partnership

California State University – Northridge and Dignity Health Northridge Hospital Medical Center have entered a health partnership, the school has announced.

Amgen to Collaborate With CytomX on Cancer Treatment

Amgen Inc. today announced that it has entered into a strategic collaboration in immune-oncology with CytomX Therapeutics Inc. in San Francisco.

MannKind Gains Another 20 Percent on New FDA Label

Following a 7 percent increase Monday, shares of MannKind Corp. stayed bullish, closing up more than 20 percent increase on Tuesday.

Simulations Plus Releases Preliminary Results for Last Time

Simulations Plus Inc. released preliminary results for its fiscal fourth quarter and fiscal 2017, saying that it’s the last time it will release results prior to officially filings with the Securities and Exchange Commission.

MannKind Moves Higher on Afrezza Label Update

MannKind Corp. today announced that the U.S. Food & Drug Administration has updated prescribing information for Afrezza, the company’s sole commercial product.

B. Riley Subsidiary Hires Health Care Analysts

Investment bank FBR Capital Markets & Co. has hired four analysts to cover the health care, pharmaceutical, medical devices and diagnostics industries.

Preview: Amgen's Slow Road to Profits

New cancer biosimilar faces lengthy run of litigation.

Sale Date Set for Amgen's Biosimilar of Humira

Amgen Inc.’s Amjevita, a biosimilar of the bestselling drug in the world, will launch in Europe and the United States in 2018 and 2023, respectively, the company announced.

Amgen Partnership Takes Biosimilars to China

Amgen Inc. on Tuesday announced an exclusive agreement with Simcere Pharmaceutical Group to co-develop and commercialize four biosimilar drugs in China.

Lab Closure Means Layoffs for 55 Workers

Providence Saint Joseph Medical Center will lay off approximately 55 people in late October, according to a notice provided to the state’s Employment Development Department.

Amgen Reaffirms Guidance After Hurricane Maria

Amgen Inc. does not anticipate interruptions in its drug supply caused by Hurricane Maria and affirmed its guidance for the year, the company announced Monday.

Biotech Execs Foresee Industry's Critical Mass in Region

Biotech startup executives discussed the industry’s challenges and opportunities in the Valley region during the Corporate Leaders Breakfast organized by California Lutheran University on Friday at the Ronald Reagan Presidential Library in Simi Valley.

FDA Approves Amgen Cancer Treatment Mvasi

The U.S. Food and Drug Administration announced it has approved Amgen Inc.’s biosimilar drug Mvasi for treatment of multiple types of cancer. It is the first biosimilar approved in the U.S. for cancer.